Nevro
Focus: Nevro is a medical device company specializing in spinal cord stimulation (SCS) and neuromodulation therapies for chronic pain, particularly back pain and neuropathic conditions. The company operates in the musculoskeletal/pain management space with a focused portfolio of FDA-cleared and investigational devices.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Nevro
AI assessmentNot HiringNo open roles listed right now. Follow Nevro to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
14 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growth
Flagship high-frequency SCS platform with multiple indication expansions in pain market; primary commercial driver and clinical validation engine.
10 kHz SCS
Help build intelligence for Nevro
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.